2030, Documentation and Pharmaceutical Manufacturing

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2030

Documentation

Pharmaceutical Manufacturing

Navigating the regulatory challenge of PFAS for pharmaceutical manufacturers

European Pharmaceutical Review

APRIL 10, 2025

In the EU, a joint PFAS Restriction Proposal under REACH was submitted, aiming for a full ban by 2028/2030. This poses a significant challenge for pharmaceutical manufacturers, not least because of the technical challenges related to operations, supply chain and the environment. There is worldwide concern around the use of PFAS.

Pharmaceutical Manufacturing

Pharmaceutical Manufacturing Packaging Documentation Communication

QMS market to value nearly $4b by 2030

European Pharmaceutical Review

JULY 18, 2023

A market report by Meticulous Research has reported that rising pressure to reduce overall process costs has meant many pharma and biotech manufacturers are focusing on streamlining their processes by using quality management systems. According to the research, the pharmaceutical quality management systems market is projected to reach $3.97

Documentation

Documentation Pharmaceutical Companies Pharmaceutical Companies Pharmaceutical Manufacturing

Pharmacist Digest

Navigating the regulatory challenge of PFAS for pharmaceutical manufacturers

QMS market to value nearly $4b by 2030

Stay Connected